These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11758772)

  • 1. Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model.
    Charman SA; McLennan DN; Edwards GA; Porter CJ
    Pharm Res; 2001 Nov; 18(11):1620-6. PubMed ID: 11758772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of absorption promoters on pulmonary insulin bioactivity.
    Kumar TM; Misra A
    AAPS PharmSciTech; 2003; 4(2):E15. PubMed ID: 12916897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equivalent Electrical Circuit Approach to Enhance a Transducer for Insulin Bioavailability Assessment.
    Mancino F; Nouri H; Moccaldi N; Arpaia P; Kanoun O
    IEEE J Transl Eng Health Med; 2024; 12():533-541. PubMed ID: 39155919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic vessels in the age of cancer immunotherapy.
    Karakousi T; Mudianto T; Lund AW
    Nat Rev Cancer; 2024 Jun; 24(6):363-381. PubMed ID: 38605228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa.
    Rosenstock J; Juneja R; Beals JM; Moyers JS; Ilag L; McCrimmon RJ
    Endocr Rev; 2024 May; 45(3):379-413. PubMed ID: 38224978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an In Vitro System To Emulate an In Vivo Subcutaneous Environment: Small Molecule Drug Assessment.
    Lou H; Hageman MJ
    Mol Pharm; 2022 Nov; 19(11):4017-4025. PubMed ID: 36279508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity and protein composition of venoms of Hottentotta saulcyi, Hottentotta schach and Androctonus crassicauda, three scorpion species collected in Iran.
    Boghozian A; Nazem H; Fazilati M; Hejazi SH; Sheikh Sajjadieh M
    Vet Med Sci; 2021 Nov; 7(6):2418-2426. PubMed ID: 34358414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins.
    Jarvi NL; Balu-Iyer SV
    BioDrugs; 2021 Mar; 35(2):125-146. PubMed ID: 33523413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice.
    Vollack-Hesse N; Oleshko O; Werwitzke S; Solecka-Witulska B; Kannicht C; Tiede A
    Blood; 2021 Feb; 137(8):1072-1081. PubMed ID: 32877516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies.
    Datta-Mannan A; Estwick S; Zhou C; Choi H; Douglass NE; Witcher DR; Lu J; Beidler C; Millican R
    MAbs; 2020 Jan; 12(1):1770028. PubMed ID: 32486889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review of Device Parameters and Design of Studies Bridging Biologic-Device Combination Products Using Prefilled Syringes and Autoinjectors.
    Hu P; Wang J; Florian J; Shatzer K; Stevens AM; Gertz J; Ji P; Huang SM; Zineh I; Wang YC
    AAPS J; 2020 Feb; 22(2):52. PubMed ID: 32107671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Inter-Individual Variability in Monoclonal Antibody Disposition.
    Thomas VA; Balthasar JP
    Antibodies (Basel); 2019 Dec; 8(4):. PubMed ID: 31817205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanofibrous antibiotic-eluting matrices: Biocompatibility studies in a rat model.
    Passos PC; Moro J; Barcelos RCS; Da Rosa HZ; Vey LT; Bürguer ME; Maciel RM; Danesi CC; Edwards PC; Bottino MC; Kantorski KZ
    J Biomed Mater Res B Appl Biomater; 2020 Feb; 108(2):306-315. PubMed ID: 31016876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the acute effects of exercise on insulin kinetics in type 1 diabetes.
    Frank S; Jbaily A; Hinshaw L; Basu R; Basu A; Szeri AJ
    J Pharmacokinet Pharmacodyn; 2018 Dec; 45(6):829-845. PubMed ID: 30392154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins.
    Turner MR; Balu-Iyer SV
    J Pharm Sci; 2018 May; 107(5):1247-1260. PubMed ID: 29336981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and Interspecies Scaling of rhTNF-
    Chen X; DuBois DC; Almon RR; Jusko WJ
    Drug Metab Dispos; 2017 Jul; 45(7):798-806. PubMed ID: 28411279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of 20-kDa PEG to Insulin Lispro Alters Absorption and Decreases Clearance in Animals.
    Knadler MP; Nguyen TH; Campanale K; De Veer MJ; Beals JM; Li S; Hansen R; Siesky A; Michael MD; Porter CJ
    Pharm Res; 2016 Dec; 33(12):2920-2929. PubMed ID: 27528391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.
    Trevaskis NL; Kaminskas LM; Porter CJ
    Nat Rev Drug Discov; 2015 Nov; 14(11):781-803. PubMed ID: 26471369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the lethal potency of scorpion and snake venoms and comparison between intraperitoneal and intravenous injection routes.
    Oukkache N; El Jaoudi R; Ghalim N; Chgoury F; Bouhaouala B; Mdaghri NE; Sabatier JM
    Toxins (Basel); 2014 Jun; 6(6):1873-81. PubMed ID: 24926799
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.